- Home
- UEC vs AXSM Comparison
UEC vs AXSM Comparison
Compare UEC & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | UEC | AXSM |
|---|---|---|
| Founded | 2003 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Metals and Minerals | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.8B | 7.4B |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | UEC | AXSM |
|---|---|---|
| Price | $12.35 | $154.22 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 20 |
| Target Price | $15.80 | ★ $176.00 |
| AVG Volume (30 Days) | ★ 11.0M | 479.3K |
| Earning Date | 12-10-2025 | 11-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $49,750,000.00 | ★ $561,263,000.00 |
| Revenue This Year | N/A | $66.40 |
| Revenue Next Year | $153.62 | $56.13 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 189.19 | 65.83 |
| 52 Week Low | $3.85 | $75.56 |
| 52 Week High | $17.80 | $158.57 |
Technical Indicators
Market Signals| Indicator | UEC | AXSM |
|---|---|---|
| Relative Strength Index (RSI) | 48.08 | 62.63 |
| Support Level | $11.42 | $152.41 |
| Resistance Level | $13.16 | $158.56 |
| Average True Range (ATR) | 0.95 | 4.21 |
| MACD | -0.04 | 0.15 |
| Stochastic Oscillator | 31.70 | 66.19 |
Price Performance
Historical ComparisonAbout UEC Uranium Energy Corp.
Uranium Energy Corp is a uranium mining company engaged in the exploration, extraction, and processing of uranium and titanium concentrates across projects in the United States, Canada, and Paraguay. The Company operates through multiple segments, including uranium mining activities in Wyoming, Texas, Saskatchewan, and other regions, along with a corporate segment focused on investments and uranium inventory trading. It is expanding its portfolio of low-cost uranium projects in stable North American locations and operates a Wyoming-based ISR (In-Situ Recovery) Hub and Spoke platform. This platform is supported by two fully operational central processing plants and seven U.S. ISR uranium projects.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.